Pharmacy

Alexion Pharmaceuticals agreed to pay $13 million to settle allegations that it used charities to pay kickbacks to Medicare patients, according to a STAT news report.

CVS Health reported a net loss of $421 million in the fourth quarter of 2018, down from a profit of $3.29 billion the same period a year earlier.

The Allergan board selected former Celgene CEO and Chairman Bob Hugin to serve on its board of directors, effective Feb. 19.

More details have emerged from a lawsuit filed by 47 states that accuses 17 generic drugmakers of engaging in a scheme to fix prices, according to STAT, who obtained an unredacted version of the complaint.

Immune Pharmaceuticals, a New Jersey-based biopharmaceutical company specializing in the development of treatments for immunologic and inflammatory diseases, filed for Chapter 11 bankruptcy Feb. 19.

In a setback to states working to rein in prescription drug costs, the U.S. Supreme Court rejected Maryland's bid to revive a law aimed at preventing price gouging by drugmakers, Reuters reports.

After facing pressure from hedge fund Appaloosa LP to separate the roles of chairman and CEO, Allergan announced its intent to do so.

Ohio Attorney General Dave Yost wants UnitedHealth Group's pharmacy benefit arm OptumRx to repay $16 million to the Bureau of Workers' Compensation, according to The Columbus Dispatch.

CVS Health and Walgreens, the two largest retail pharmacy chains in the U.S., have both opened redesigned health-focused stores.

Drugstores at CVS and Walgreens are being renovated to look more like physician offices, according to CNBC.